Category:BTK inhibitors

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

A class of drugs that inhibit Bruton's tyrosine kinase (BTK). The first specific drug approved in this class is Ibrutinib (Imbruvica), although Dasatinib (Sprycel) has some demonstrated degree of BTK inhibition[1].


Pages in category "BTK inhibitors"

The following 7 pages are in this category, out of 7 total.